Diagnostic methods and agents
CA 2452202 A1 · Owner: The Walter And Eliza Hall Institute Of Medical Research · Inventors: Foletta, Victoria Caitlin; Bernard, Ora
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to a method for detecting an aberrant cell in a subject or in a biological sample from said subject and agents useful for same. The presence of the aberrant cell or group of aberrant cells provides an indication of a particular disease or condition or a propensity for development of a disease or condition. More particularly the present , invention contemplates a method for detecting a cell associated with cancer or having a propensity to develop into a cancer cell in a subject or in a biological sample from said subject by determining the relative increase in the presence of a LIM kinase protein or a related enzyme or a relative increase in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 27, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.